| Members |
targetComponentId |
| Carboxy-lyase |
Decarboxylase |
| Carboxylic ester hydrolase |
Carboxylesterase |
| karboximetylcellulosanatrium + hydroxiapatit, injicerbart implantat, spruta 1 ml |
Carmellose and hydroxyapatite only product in parenteral dose form |
| karboximetylcellulosanatrium 16,58 %, oral pasta |
Carmellose 166 mg/g oral paste |
| Carbuncle of head, except face |
Carbuncle of head |
| Carbuncle of other specified site |
Carbuncle of skin and/or subcutaneous tissue (disorder) |
| karcinoidtumör (förutom i appendix, M-82401) |
Malignant carcinoid tumor |
| Carcinoid tumor, argentaffin |
Carcinoid tumor - argentaffin |
| carcinoma in situ, kategori |
Carcinoma in situ (morphologic abnormality) |
| Carcinoma in situ neoplastic process |
Carcinoma in situ (morphologic abnormality) |
| Carcinoma in situ tumour |
Carcinoma in situ (disorder) |
| carcinoma in situ |
Carcinoma in situ (morphologic abnormality) |
| bröstcancerliknande karcinom |
Carcinoma (morphologic abnormality) |
| karcinom |
Carcinoma (morphologic abnormality) |
| Cardiac end diastolic volume, function (observable entity) |
Cardiac end-diastolic volume (observable entity) |
| biverkning av hjärtglykosid |
Adverse reaction to Digitalis glycoside |
| Cardiac status not worse than preoperative baseline |
Cardiac status is consistent with or improved from preoperative baseline (finding) |
| Cardiospasm |
Achalasia of esophagus |
| kardiotuberkulös cirros |
Cirrhosis of liver |
| Care of venous dissection |
Procedure on cardiovascular system |
| Care plan |
Care plan (record artifact) |
| vårdplan |
Care plan (record artifact) |
| Care plan |
Care plan (record artifact) |
| vårdar person med psykisk funktionsnedsättning i beroendeställning |
Caregiver of dependent with intellectual disability |
| Carglumic acid 200mg dispersible tablet |
Product containing precisely carglumic acid 200 milligram/1 each tablet for conventional release oral suspension (clinical drug) |
| karglutamsyra 200 mg, dispergerbar tablett |
Product containing precisely carglumic acid 200 milligram/1 each tablet for conventional release oral suspension (clinical drug) |
| omhändertagande miljö |
Caring environment (finding) |
| Carlavirus group |
Genus Carlavirus (organism) |
| karmellosnatrium 0,5 %, ögondroppar |
Carmellose sodium 5 mg/mL eye solution |
| karmellosnatrium 1 %, ögondroppar |
Product containing precisely carmellose sodium 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
| karmellosnatrium 1 %, ögondroppar för engångsbruk |
Product containing precisely carmellose sodium 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
| karmustinskiva 7,7 mg |
Product containing precisely carmustine 7.7 milligram/1 each prolonged-release intralesional implant (clinical drug) |
| Carnobacterium piscicola |
Carnobacterium maltaromaticum (organism) |
| Carotenosis cutis |
Carotene pigmentation of skin |
| Carpenter-Waziris syndrom |
X-linked intellectual disability hypotonic face syndrome |
| karvedilol 10 mg, kapsel med kontrollerad frisättning |
Product containing only carvedilol in oral dose form (medicinal product form) |
| karvedilol 10 mg, depåkapsel |
Product containing only carvedilol in oral dose form (medicinal product form) |
| karvedilol 20 mg, kapsel med kontrollerad frisättning |
Product containing only carvedilol in oral dose form (medicinal product form) |
| karvedilol 20 mg, depåkapsel |
Product containing only carvedilol in oral dose form (medicinal product form) |
| karvedilol 40 mg, kapsel med kontrollerad frisättning |
Product containing only carvedilol in oral dose form (medicinal product form) |
| karvedilol 40 mg, depåkapsel |
Product containing only carvedilol in oral dose form (medicinal product form) |
| karvedilol 80 mg, kapsel med kontrollerad frisättning |
Product containing only carvedilol in oral dose form (medicinal product form) |
| karvedilol 80 mg, depåkapsel |
Product containing only carvedilol in oral dose form (medicinal product form) |
| Carya illinoensis |
Carya illinoinensis (organism) |
| extrakt av pekannöt |
Carya illinoinensis diagnostic allergen extract (product) |
| RAST-test: pekannötter |
Carya illinoinensis specific immunoglobulin E antibody measurement (procedure) |
| Casmerodius albus |
Ardea alba (organism) |
| Casting or strapping procedure |
Stabilization |
| Casualty,not due to war, of accident NOS |
Accidental event (event) |
| vaccin mot kattallergi |
Cat allergy vaccine (product) |
| Cat scratch disease |
Cat scratch disease |
| katekin 15 %, salva för lokalt bruk |
Catechin only product |
| Catheter patency solutions |
Pharmaceutical fluid or solution (product) |
| katjon |
Electrolyte cation (substance) |
| Cauda equina injury without bone injury |
Cauda equina injury without spinal bone injury (disorder) |
| Cauda equina injury without bony injury |
Cauda equina injury without spinal bone injury (disorder) |
| blomkål |
Cauliflower (substance) |
| blomkål, livsmedel |
Cauliflower (substance) |
| frätskada i huden |
Chemical burn of skin |
| CdE genotype |
CdE haplotype (finding) |
| cefaklor 125 mg/5 ml, sockerfri suspension |
Cefaclor 25 mg/mL oral suspension |
| Cefaclor 187mg/5mL suspension |
Product containing precisely cefaclor anhydrous (as cefaclor) 37.4 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| cefaklor 250 mg, tuggtablett |
Product containing precisely cefaclor 250 milligram/1 each conventional release chewable tablet (clinical drug) |
| cefaklor 250 mg/5 ml, sockerfri suspension |
Cefaclor 50 mg/mL oral suspension |
| cefaklor 375 mg, tablett med modifierad frisättning |
Product containing precisely cefaclor 375 milligram/1 each prolonged-release oral tablet (clinical drug) |
| Cefaclor 375mg tablet |
Product containing precisely cefaclor 375 milligram/1 each prolonged-release oral tablet (clinical drug) |
| Cefaclor 375mg/5mL suspension |
Cefaclor anhydrous (as cefaclor) 75 mg/mL oral suspension |
| cefaklor 500 mg, tablett med modifierad frisättning |
Product containing only cefaclor in oral dose form (medicinal product form) |
| cefaklor 500 mg, depåtablett |
Product containing only cefaclor in oral dose form (medicinal product form) |
| Cefaclor anhydrous 250mg capsule |
Product containing precisely cefaclor 250 milligram/1 each conventional release oral capsule (clinical drug) |
| cefaklorextrakt |
Product containing cefaclor (medicinal product) |
| Cefaclor monohydrate 125mg/5 mL powder for oral suspension |
Cefaclor 25 mg/mL oral suspension |
| cefaklormonohydrat 187 mg/5 ml, pulver till oral suspension |
Product containing precisely cefaclor anhydrous (as cefaclor) 37.4 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Cefaclor monohydrate 187mg/5mL suspension |
Product containing precisely cefaclor anhydrous (as cefaclor) 37.4 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Cefaclor monohydrate 250mg/5mL powder for oral suspension |
Cefaclor 50 mg/mL oral suspension |
| cefaklormonohydrat 375 mg/5 ml, pulver till oral suspension |
Cefaclor anhydrous (as cefaclor) 75 mg/mL oral suspension |
| Cefaclor monohydrate 375mg/5ml suspension |
Cefaclor anhydrous (as cefaclor) 75 mg/mL oral suspension |
| Cefadroxil 500mg capsule |
Product containing precisely cefadroxil 500 milligram/1 each conventional release oral capsule (clinical drug) |
| Cefadroxil 500mg capsule |
Product containing precisely cefadroxil 500 milligram/1 each conventional release oral capsule (clinical drug) |
| Cefadroxil monohydrate 125mg/5mL powder for oral suspension |
Cefadroxil 25 mg/mL oral suspension |
| Cefadroxil monohydrate 250mg/5 mL suspension |
Cefadroxil 50 mg/mL oral suspension |
| Cefadroxil monohydrate 250mg/5mL powder for oral suspension |
Cefadroxil 50 mg/mL oral suspension |
| Cefadroxil monohydrate 250mg/5mL suspension |
Cefadroxil 50 mg/mL oral suspension |
| Cefadroxil monohydrate 500mg/5mL powder for oral suspension |
Cefadroxil 100 mg/mL oral suspension |
| Cefadroxil monohydrate 500mg/5mL suspension |
Cefadroxil 100 mg/mL oral suspension |
| cefalexin 25 mg/ml, oral suspension |
Cefalexin anhydrous (as cefalexin) 25 mg/mL oral suspension |
| cefalexin 50 mg/ml, oral suspension |
Product containing precisely cefalexin anhydrous (as cefalexin) 50 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| cefazolin 250 mg, pulver till injektionsvätska, flaska |
Cefazolin only product in parenteral dose form |
| Cefixime 100mg/5 mL powder for suspension |
Product containing precisely cefixime 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| cefixim 100 mg/5 ml, oral suspension till barn |
Product containing precisely cefixime 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Cefixime 100mg/5mL suspension |
Product containing precisely cefixime 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| cefixim 200 mg/5 ml, oral suspension |
Cefixime 40 mg/mL oral suspension |
| cefmetazolnatrium 1 g, pulver till injektionsvätska, flaska |
Product containing precisely cefmetazole (as cefmetazole sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
| cefmetazolnatrium 2 g, pulver till injektionsvätska, flaska |
Cefmetazole (as cefmetazole sodium) 2 g powder for solution for injection vial |
| Cefoperazone + cefoperazone sodium 2gm/0ns injection |
Cefoperazone (as cefoperazone sodium) 2 g powder for solution for injection vial |
| Cefoperazone 2gm/cefoperazone sodium 0ns injection solution vial |
Cefoperazone (as cefoperazone sodium) 2 g powder for solution for injection vial |
| cefoperazonnatrium 10 g, pulver till injektionsvätska, flaska |
Cefoperazone (as cefoperazone sodium) 10 g powder for solution for injection vial |
| Cefoperazone sodium 1g injection (pdr for recon) |
Product containing precisely cefoperazone (as cefoperazone sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
| cefoperazonnatrium 1 g, pulver till injektionsvätska, flaska |
Product containing precisely cefoperazone (as cefoperazone sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
| Cefoperazone sodium 1g/bag injection |
Product containing precisely cefoperazone (as cefoperazone sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
| Cefoperazone sodium 2g injection (pdr for recon) |
Cefoperazone (as cefoperazone sodium) 2 g powder for solution for injection vial |
FHIR